Pernix Therapeutics Holdings, Inc.
PTX
PTX was delisted on the 4th of March, 2019.
56 hedge funds and large institutions have $5.52M invested in Pernix Therapeutics Holdings, Inc. in 2016 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 20 reducing their positions, and 42 closing their positions.
30% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 20
36% less funds holding
Funds holding: 88 → 56 (-32)
59% less call options, than puts
Call options by funds: $17K | Put options by funds: $41K
76% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 42
87% less capital invested
Capital invested by funds: $41.6M → $5.52M (-$36.1M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$1.36M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
+$278K |
| 3 |
Tudor Investment Corp
Stamford,
Connecticut
|
+$141K |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$107K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$95.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
-$6.39M |
| 2 |
ACA
Avoro Capital Advisors
New York
|
-$4.08M |
| 3 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$3.38M |
| 4 |
Morgan Stanley
New York
|
-$3.32M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.63M |
PTX Hedge Fund Activity: Q2 2016 in Review
56 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Pernix Therapeutics Holdings, Inc. (PTX) for Q2 2016, worth a combined $5.52M — down 87% from $41.6M a quarter earlier.
Sellers outnumbered buyers: 42 funds closed out of PTX and 10 opened new positions — a net loss of 32 holders — while 20 trimmed existing stakes and 14 added.
The largest buyer was Renaissance Technologies, adding an estimated $1.36M. The largest seller was Broadfin Capital, exiting entirely with an estimated $6.39M sold.
- 56 institutional investors held Pernix Therapeutics Holdings, Inc. (PTX) as of Q2 2016, down from 88 in Q1 2016.
- Funds reported $5.52M of Pernix Therapeutics Holdings, Inc. stock for Q2 2016, down 87% quarter-over-quarter.
- 10 funds opened new Pernix Therapeutics Holdings, Inc. positions in Q2 2016 and 42 closed out, a net change of -32 holders.
- The largest Pernix Therapeutics Holdings, Inc. buyer in Q2 2016 was Renaissance Technologies, an estimated $1.36M added.
- The largest Pernix Therapeutics Holdings, Inc. seller in Q2 2016 was Broadfin Capital, an estimated $6.39M sold.
Based on aggregated 13F filings for Q2 2016.